A Managing Director, Ted invests across asset classes, with time allocated to internal management, asset allocation and firm strategy. Presently, he is a director at 4G Clinical, Cartesian Therapeutics, Eastern Point Capital, Millstone Medical Outsourcing, Nanoscale Powders, Spotted, SRS Medical, and Zixi. He has led or co-led a number of Schooner investments including Seventh Generation (acquired by Unilever), SHIFT (acquired by Marlin Equity), Topokine Therapeutics (acquired by Allergan), Mimetogen Pharmaceuticals (acquired by Allergan), StyleFeeder (acquired by Time Inc.), and Best Doctors (acquired by Brown Brothers). Prior to joining Schooner in 2003, Ted worked for Fidelity Capital, Leo Burnett and subsidiaries of The Washington Post Company. He was also a mediocre entrepreneur. Ted co-chairs Friends of Dartmouth Soccer and is a past director at several not-for-profits. He has degrees from Dartmouth College (cum laude, Chinese language and culture) and Harvard Business School.